Prevalence and factors associated with cervical cancer preventive screening in a Peruvian region

Estudios originales

Published on 25 de septiembre de 2023 | http://doi.org/10.5867/medwave.2023.08.2709

Prevalence and factors associated with cervical cancer preventive screening in a Peruvian region

Crude and adjusted indicators of association between socio-sanitary factors and use of screening tests.

Preventive screening			Crude model		Adjusted model¹
No	Yes	P value	RPc (95% CI)	P value	RPa (95% CI)	P value
Use of contraceptive methods
375 (55.0)	307 (45.0)	< 0.001	Ref.		Ref.
192 (41.4)	272 (58.6)		1.30 (1.16 to 1.45)	< 0.001	1.28 (1.16 to 1.41)	< 0.001
Health insurance
68 (58.1)	49 (41.9)	0.048	Ref.		Ref.
499 (48.5)	530 (51.5)		1.23 (0.98 to 1.53)	0.067	1.31 (1.07 to 1.60)	0.008
Received recommendation from healthcare personnel to undergo screening
286 (86.7)	44 (13.3)	< 0.001	Ref.		Ref.
281 (34.4)	535 (65.6)		4.91 (3.17 to 6.50)	< 0.001	4.80 (3.63 to 6.35)	< 0.001
Do you have a gynecological disease?
524 (49.8)	528 (50.2)	0.45	Ref.		Ref.
43 (45.7)	51 (54.3)		1.08 (0.88 to 1.31)	0.434	1.05 (0.89 to 1.24)	0.506
Do you have a family member/friend with cervical cancer?
467 (49.6)	475 (50.4)	0.886	Ref.		Ref.
100 (49.6)	104 (51.0)		1.01 (0.87 to 1.17)	0.885	1.01 (0.89 to 1.14)	0.851
Worries about developing cervical cancer
231 (60.6)	150 (39.4)	< 0.001	Ref.		Ref
336 (43.9)	429 (56.1)		1.42 (1.23 to 1.63)	< 0.001	1.20 (1.06 to 1.36)	0.003

95% CI, 95% confidence interval. CPR, crude prevalence ratio. aPR, adjusted prevalence ratio. Ref., reference variable.

Notes: ¹Adjusted for all variables in the table.

Source: Own database from the study results.